Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRPM2 Gene Polymorphism in Relation to NLRP3 Inflammasome Expression in Vitiligo Patients

NCT07232238 is registered in ClinicalTrials.gov with Aswan University as lead sponsor.

NCT NCT07232238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07232238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRPM2 Gene Polymorphism in Relation to NLRP3 Inflammasome Expression in Vitiligo Patients
Lead sponsor
Aswan University
Phase
Observational
Overall status
Active, not recruiting
Start date
October 20, 2025
Completion date
May 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitiligo